278 related articles for article (PubMed ID: 9275443)
1. [Hormonal therapy for the synchronization between donor and recipient in an oocyte donation and surrogacy fertilization in vitro-embryo transfer program].
Zhang L; Chen G; Liu P
Zhonghua Fu Chan Ke Za Zhi; 1996 Aug; 31(8):486-9. PubMed ID: 9275443
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
3. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
4. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
5. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate.
Yang JH; Chen HF; Lien YR; Chen SU; Ho HN; Yang YS
J Reprod Med; 2001 May; 46(5):434-8. PubMed ID: 11396368
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
7. [Effects of electroacupuncture on in vitro fertilization-embryo transfer (IVF-ET) of patients with poor ovarian response].
Chen J; Liu LL; Cui W; Sun W
Zhongguo Zhen Jiu; 2009 Oct; 29(10):775-9. PubMed ID: 19873910
[TBL] [Abstract][Full Text] [Related]
8. The significance of premature luteinization in an oocyte-donation programme.
Melo MA; Meseguer M; Garrido N; Bosch E; Pellicer A; Remohí J
Hum Reprod; 2006 Jun; 21(6):1503-7. PubMed ID: 16648153
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience employing co-culture of human embryos with autologous human endometrial epithelial cells.
Rubio C; Simón C; Mercader A; Garcia-Velasco J; Remohí J; Pellicer A
Hum Reprod; 2000 Dec; 15 Suppl 6():31-8. PubMed ID: 11261481
[TBL] [Abstract][Full Text] [Related]
10. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
[TBL] [Abstract][Full Text] [Related]
11. [The study on the relationship between luteal phase serum sex hormone levels and pregnancy outcome in in vitro fertilization embryo transfer cycle].
Tian X; Zhang L; Yang C
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):484-6. PubMed ID: 10806749
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effects of oocyte cryopreservation in assisted reproduction technology].
Wang W; Yan ZJ; Cai LB; Chai DC; Liu CZ; Mao YD; Liu JY
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(39):2755-8. PubMed ID: 19080449
[TBL] [Abstract][Full Text] [Related]
13. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
[TBL] [Abstract][Full Text] [Related]
14. Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study.
Gelbaya TA; Nardo LG; Hunter HR; Fitzgerald CT; Horne G; Pease EE; Brison DR; Lieberman BA
Fertil Steril; 2006 Mar; 85(3):603-9. PubMed ID: 16500326
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
16. Comparison of GnRH antagonists and flareup GnRH agonists in donor oocyte cycles.
Wei AY; Mijal KA; Christianson MS; Schouweiler CM; Lindheim SR
J Reprod Med; 2008 Mar; 53(3):147-50. PubMed ID: 18441715
[TBL] [Abstract][Full Text] [Related]
17. A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH.
Martínez F; Boada M; Coroleu B; Clua E; Parera N; Rodríguez I; Barri PN
Hum Reprod; 2006 Aug; 21(8):2121-5. PubMed ID: 16632462
[TBL] [Abstract][Full Text] [Related]
18. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
19. Transfer and uterine factors are the major recipient-related determinants of success with donor eggs.
Zenke U; Chetkowski RJ
Fertil Steril; 2004 Oct; 82(4):850-6. PubMed ID: 15482759
[TBL] [Abstract][Full Text] [Related]
20. [The value of hormonal and sonographic parameters in the diagnosis of disordered and normal early pregnancy].
Wiedemann R; Strowitzki T; Sandner R; Luppa P; Hepp H
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):237-42. PubMed ID: 2470635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
